Affiliated Hospital of Qinghai University — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Affiliated Hospital of Qinghai University appears in 14 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials14

Recruiting shown5

Roles2

SourceClinicalTrials.gov

Clinical trials

14 shown

Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast CancerNCT06772935 · lead sponsor · 2025-06-01

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot SyndromeNCT06602167 · lead sponsor · 2024-10-08

Genetic Predictors of Response to Acupuncture for Cancer-related Fatigue Among Breast Cancer Patients After ChemotherapyNCT05094310 · lead sponsor · 2022-04-01

Personalized Electroacupuncture Treatment for Chemotherapy-induced Nausea and Vomiting in Breast Cancer (PET)NCT05275569 · lead sponsor · 2022-03-15

Precision Acupuncture in the Treatment of Peripheral Neuropathy After Taxanes Chemotherapy in Breast CancerNCT05099562 · lead sponsor · 2021-12-01

Genetic Predictors to Acupuncture Response for Arthralgia Induced by Aromatase Inhibitors in Patients With Breast CancerNCT05125432 · lead sponsor · 2021-11-25

Acupuncture for Stiffness of Joint Related to Aromatase Inhibitors in Patients With Early-Stage Breast CancerNCT05098951 · lead sponsor · 2021-10-20

Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High AltitudeNCT05063643 · lead sponsor · 2021-10-01

A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate CancerNCT07474142 · collaborator · 2026-03-03

Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate CancerNCT07553780 · collaborator · 2021-03-07

Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate CancerNCT07531329 · collaborator · 2021-03-05

Plasma Exosome RNA to Diagnose Prostate CancerNCT06604130 · collaborator · 2021-03-12

ENROLLING_BY_INVITATION

Impact of Left Bundle Branch Area Pacing vs. Right Ventricular Pacing in Atrioventricular Block (LEAP-Block)NCT04730921 · collaborator · 2020-11-13

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast CancerNCT03351062 · collaborator · 2017-11-01

Drugs studied in this sponsor's trials

2 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Affiliated Hospital of Qinghai University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

tamoxifen1

toremifene1

tamoxifen RxCUI 10324 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial toremifene RxCUI 38409 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor8

collaborator6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.